JP2018515442A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018515442A5 JP2018515442A5 JP2017552910A JP2017552910A JP2018515442A5 JP 2018515442 A5 JP2018515442 A5 JP 2018515442A5 JP 2017552910 A JP2017552910 A JP 2017552910A JP 2017552910 A JP2017552910 A JP 2017552910A JP 2018515442 A5 JP2018515442 A5 JP 2018515442A5
- Authority
- JP
- Japan
- Prior art keywords
- flt
- composition
- antibody
- binding fragment
- antigen binding
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562144241P | 2015-04-07 | 2015-04-07 | |
| US62/144,241 | 2015-04-07 | ||
| PCT/US2016/026420 WO2016164567A1 (en) | 2015-04-07 | 2016-04-07 | Anti-flt-1 antibodies in treating bronchopulmonary dysplasia |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018515442A JP2018515442A (ja) | 2018-06-14 |
| JP2018515442A5 true JP2018515442A5 (enExample) | 2019-05-16 |
| JP6797826B2 JP6797826B2 (ja) | 2020-12-09 |
Family
ID=55969453
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017552910A Active JP6797826B2 (ja) | 2015-04-07 | 2016-04-07 | 気管支肺異形成症の治療における抗Ｆｌｔ−１抗体 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US10738123B2 (enExample) |
| EP (1) | EP3280737B1 (enExample) |
| JP (1) | JP6797826B2 (enExample) |
| CN (1) | CN107690335A (enExample) |
| AU (1) | AU2016246730B2 (enExample) |
| BR (1) | BR112017021413A2 (enExample) |
| HK (1) | HK1249908A1 (enExample) |
| MA (1) | MA41908A (enExample) |
| MX (2) | MX391847B (enExample) |
| WO (1) | WO2016164567A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3018191C (en) * | 2016-03-31 | 2022-01-25 | ImMutriX Therapeutics, Inc. | Method for extracorporeal treatment of preeclampsia and related disorders |
| WO2019246521A1 (en) | 2018-06-22 | 2019-12-26 | Shire Human Genetic Therapies, Inc. | Anti-flt-1 antibodies in treating bronchopulmonary dysplasia |
| EP3936054A1 (en) * | 2020-07-08 | 2022-01-12 | Assistance Publique - Hôpitaux de Paris | Method of prognosis of bronchopulmonary dysplasia in premature infants |
| EP4388011A4 (en) * | 2021-08-16 | 2025-07-30 | Janssen Biotech Inc | ANTI-VEGFR1 ANTIBODIES AND THEIR USES |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7435419B2 (en) * | 2002-07-19 | 2008-10-14 | Beth Israel Deaconess Medical Center | Methods of diagnosing and treating pre-eclampsia or eclampsia |
| US7335362B2 (en) * | 2002-07-19 | 2008-02-26 | Beth Israel Deaconess Medical Center | Methods of treating pre-eclampsia or eclampsia |
| BRPI0312818B8 (pt) * | 2002-07-19 | 2021-05-25 | Beth Israel Deaconess Medical Ct Inc | uso de uma medida do nível do polipeptídeo sflt-1 em uma amostra de uma paciente e uso de uma medida dos níveis de pelo menos dois dos peptídeos sflt1, vegf livre ou polipeptídio pigf livre em uma amostra de um paciente usando um métrico |
| DK1819358T3 (da) | 2004-11-18 | 2014-10-27 | Imclone Llc | Antistoffer mod vaskulær endothel-vækstfaktor-receptor-1 |
| US20060153835A1 (en) * | 2005-01-12 | 2006-07-13 | Smith Henry J | Treatment of pre-eclampsia in pregnant women using targeted apheresis |
| US8349325B2 (en) * | 2008-12-23 | 2013-01-08 | Abbott Laboratories | Soluble FMS-like tyrosine kinase-1 (sFLT-1) antibody and related composition, kit, methods of using, and materials and method for making |
| JP6169495B2 (ja) * | 2011-02-07 | 2017-07-26 | アガミン・エルエルシー | 妊娠関連高血圧性障害を治療または予防するための方法およびシステム |
| CA2898998C (en) * | 2013-01-28 | 2023-02-14 | Regents Of The University Of Minnesota | Anti-flt-1 antibodies in treating duchenne muscular dystrophy |
| TW201517916A (zh) | 2013-03-15 | 2015-05-16 | Lilly Co Eli | Ｖｅｇｆｒ１抗體之治療用途 |
-
2016
- 2016-04-07 MX MX2017012827A patent/MX391847B/es unknown
- 2016-04-07 AU AU2016246730A patent/AU2016246730B2/en active Active
- 2016-04-07 CN CN201680032805.1A patent/CN107690335A/zh active Pending
- 2016-04-07 BR BR112017021413A patent/BR112017021413A2/pt not_active Application Discontinuation
- 2016-04-07 WO PCT/US2016/026420 patent/WO2016164567A1/en not_active Ceased
- 2016-04-07 JP JP2017552910A patent/JP6797826B2/ja active Active
- 2016-04-07 US US15/564,969 patent/US10738123B2/en active Active
- 2016-04-07 MA MA041908A patent/MA41908A/fr unknown
- 2016-04-07 EP EP16722725.5A patent/EP3280737B1/en active Active
- 2016-04-07 HK HK18109294.4A patent/HK1249908A1/zh unknown
-
2017
- 2017-10-05 MX MX2022004164A patent/MX2022004164A/es unknown
-
2019
- 2019-12-05 US US16/704,861 patent/US20200362041A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022050618A5 (enExample) | ||
| JP2022536511A (ja) | 癌の処置のための併用療法での活性化可能抗ｐｄｌ１抗体および抗ｃｔｌａ－４抗体の使用 | |
| CN113527485B (zh) | 抗人白细胞介素-4受体α抗体及其制备方法和应用 | |
| JP2009541374A5 (enExample) | ||
| RU2017120437A (ru) | Способы лечения хронического синусита с полипами носа путем введения антагониста il-4r | |
| JP2010520290A5 (enExample) | ||
| JP2008500815A5 (enExample) | ||
| JP2017507139A5 (enExample) | ||
| JP2017507652A5 (enExample) | ||
| JP2021526534A5 (enExample) | ||
| JP2011506483A5 (enExample) | ||
| JP2018512402A5 (enExample) | ||
| JP2019513726A5 (enExample) | ||
| JP2016094424A5 (enExample) | ||
| JP2021509668A (ja) | 免疫抑制なしにｉｌ−６媒介性炎症を処置する方法 | |
| JP2013508292A5 (enExample) | ||
| JP2017507945A5 (enExample) | ||
| JP2016511234A5 (enExample) | ||
| JP2020504135A5 (enExample) | ||
| JP2025508867A5 (enExample) | ||
| US20070274982A1 (en) | Anti-EpCam Immunoglobulins | |
| JP2019526244A5 (enExample) | ||
| WO2022132202A1 (en) | Combination therapy for the treatment of cancer | |
| JP2007506681A5 (enExample) | ||
| JP2018517667A5 (enExample) |